Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia

scientific article published on December 2003

Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1212/01.WNL.0000098935.36984.25
P698PubMed publication ID14694028

P2093author name stringCotman CW
Haier RJ
Lott IT
White NS
Alkire MT
Head E
Uncapher MR
P433issue12
P407language of work or nameEnglishQ1860
P921main subjectDown syndromeQ47715
P304page(s)1673-1679
P577publication date2003-12-01
P1433published inNeurologyQ1161692
P1476titleTemporal cortex hypermetabolism in Down syndrome prior to the onset of dementia
P478volume61

Reverse relations

cites work (P2860)
Q37005407(1)H-MRS metabolites in adults with Down syndrome: Effects of dementia
Q37102001Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology
Q30857550Alzheimer's Disease in Down Syndrome
Q36957698Alzheimer's disease in Down syndrome: neurobiology and risk.
Q47280353Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome
Q51804381Cognitive impairment and EEG background activity in adults with Down's syndrome: a topographic study.
Q29036002Cortical thickness correlates of specific cognitive performance accounted for by the general factor of intelligence in healthy children aged 6 to 18
Q38865366Dementia in Down's syndrome
Q33816076Dissociation of Down syndrome and Alzheimer's disease effects with imaging
Q57169774Early compensatory responses against neuronal injury: A new therapeutic window of opportunity for Alzheimer's Disease?
Q37745559Essential tremor: evolving clinicopathological concepts in an era of intensive post-mortem enquiry
Q34565270Functional alterations in memory networks in early Alzheimer's disease
Q48604859Hippocampal Proteomic Analysis Reveals Distinct Pathway Deregulation Profiles at Early and Late Stages in a Rat Model of Alzheimer's-Like Amyloid Pathology
Q35105340Increased hippocampal activation in mild cognitive impairment compared to normal aging and AD
Q46799102Insulin Resistance and Alzheimer's Disease: Bioenergetic Linkages
Q35630843Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease
Q33511725Large-scale functional brain network abnormalities in Alzheimer's disease: insights from functional neuroimaging
Q55443889Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis.
Q30989943Neuroimaging biomarkers for clinical trials of disease-modifying therapies in Alzheimer's disease
Q30051683Neuroimaging of individuals with Down’s syndrome at-risk for dementia: Evidence for possible compensatory events
Q27025698Neurological phenotypes for Down syndrome across the life span
Q38446620Neuronal Network Oscillations in Neurodegenerative Diseases.
Q47153423Neuronal hyperactivity due to loss of inhibitory tone in APOE4 mice lacking Alzheimer's disease-like pathology
Q34271896Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: an ADNI study of 515 subjects
Q35559097Plasma Amyloid-β as a Function of Age, Level of Intellectual Disability, and Presence of Dementia in Down Syndrome
Q48913317Resting State fMRI Demonstrates a Disturbance of the Cerebello-Cortical Circuit in Essential Tremor
Q36226953Single photon emission computed tomography perfusion differences in mild cognitive impairment
Q45969830Structural brain variation, age, and response time.
Q36999841The emerging neuropathology of essential tremor
Q27014791Ushering in the study and treatment of preclinical Alzheimer disease
Q33876128Why pleiotropic interventions are needed for Alzheimer's disease.
Q46797123ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.

Search more.